EyePoint, Inc. Lease, Cost
EyePoint, Inc. (EYPT) reported Lease, Cost of $1.31 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-05
- EyePoint, Inc. lease, cost for the quarter ending 2026-06-30 was $1.31M, a 13.84% increase year-over-year.
- EyePoint, Inc. lease, cost for the quarter ending 2026-03-31 was $1.18M, a 9.02% increase year-over-year.
- EyePoint, Inc. lease, cost for the quarter ending 2025-12-31 was $1.18M, a 8.26% increase year-over-year.
- EyePoint, Inc. lease, cost for the quarter ending 2025-09-30 was $1.18M, a 8.17% increase year-over-year.
- EyePoint, Inc. lease, cost for fiscal 2025 was $4.59M, a 41.18% increase from fiscal 2024.
- EyePoint, Inc. lease, cost for fiscal 2024 was $3.25M, a 106.60% increase from fiscal 2023.
- EyePoint, Inc. lease, cost for fiscal 2023 was $1.57M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.31M 10-Q · filed 2026-08-05 | $2.49M 10-Q · filed 2026-08-05 | $3.67M derived: sum of 3 quarters · filed 2026-08-05 | $4.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.18M 10-Q · filed 2026-05-07 | $2.36M derived: sum of 2 quarters · filed 2026-05-07 | $3.54M derived: sum of 3 quarters · filed 2026-05-07 | $4.69M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.36M derived: sum of 2 quarters · filed 2026-03-05 | $3.51M derived: sum of 3 quarters · filed 2026-08-05 | $4.59M 10-K · filed 2026-03-05 |
| 2025-09-30 | $1.18M 10-Q · filed 2025-11-06 | $2.33M derived: sum of 2 quarters · filed 2026-08-05 | $3.41M 10-Q · filed 2025-11-06 | $4.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.15M 10-Q · filed 2026-08-05 | $2.23M 10-Q · filed 2026-08-05 | $3.33M derived: sum of 3 quarters · filed 2026-08-05 | $4.42M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.09M 10-Q · filed 2026-05-07 | $2.18M derived: sum of 2 quarters · filed 2026-05-07 | $3.27M derived: sum of 3 quarters · filed 2026-05-07 | $3.91M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.18M derived: sum of 2 quarters · filed 2026-03-05 | $2.83M derived: sum of 3 quarters · filed 2026-03-05 | $3.25M 10-K · filed 2026-03-05 |
| 2024-09-30 | $1.09M 10-Q · filed 2025-11-06 | $1.74M derived: sum of 2 quarters · filed 2025-11-06 | $2.16M 10-Q · filed 2025-11-06 | $2.54M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $646.00K 10-Q · filed 2025-08-07 | $1.07M 10-Q · filed 2025-08-07 | $1.45M derived: sum of 3 quarters · filed 2025-08-07 | $1.85M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $403.00K 10-Q · filed 2025-05-08 | $805.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.21M derived: sum of 3 quarters · filed 2025-05-08 | $1.58M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $402.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $805.00K derived: sum of 2 quarters · filed 2025-03-06 | $1.18M derived: sum of 3 quarters · filed 2025-03-06 | $1.57M 10-K · filed 2025-03-06 |
| 2023-09-30 | $403.00K 10-Q · filed 2024-11-07 | $773.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.17M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $370.00K 10-Q · filed 2024-08-08 | $770.00K 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |